<?xml version="1.0"?>
<metadata xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/"><dc:title>Inpatient burden, costs, and characteristics of peripheral artery disease in Slovenia</dc:title><dc:creator>Furlan,	Tjaša	(Avtor)
	</dc:creator><dc:creator>Jug,	Borut	(Avtor)
	</dc:creator><dc:creator>Farkaš-Lainščak,	Jerneja	(Avtor)
	</dc:creator><dc:creator>Gavrić,	Dalibor	(Avtor)
	</dc:creator><dc:creator>Ograjenšek,	Irena	(Avtor)
	</dc:creator><dc:creator>Došenović Bonča,	Petra	(Avtor)
	</dc:creator><dc:subject>peripheral artery disease</dc:subject><dc:subject>chronic limb-threatening ischemia</dc:subject><dc:subject>intermittent claudication</dc:subject><dc:subject>hospitalisation</dc:subject><dc:subject>mortality</dc:subject><dc:description>Aims: We assessed inpatient burden, costs, demographics, co-morbidity patterns, and outcomes of peripheral artery disease (PAD) in Slovenia. 
Methods: We included patients hospitalised for PAD (primary diagnosis international classification of disease, tenth revision code I70.2–I70.9) in Slovenia between January 1st, 2015, and December 31st, 2022. We estimated crude and age-standardised hospitalisation rates, hospitalisation reimbursement costs, patient characteristics (age and sex distribution, disease severity and prevalence of co-morbidities), uptake of revascularisation, major amputations and in-hospital mortality.
Results: We included 15,978 patients (60% men, median age 72 years, 32% chronic limb-threatening ischemia) with 27,139 hospital episodes yielding a mean of ~3,400 hospitalisations per year (hospitalisation rate 161 per 100,000/year). Median direct cost (inflation-adjusted to 2025) per hospital episode was €3,177, yielding total costs of €10.8 million/year. The most common co-morbidities were arterial hypertension (35%), dyslipidemia (21%) and diabetes mellitus (19%), with a significantly higher prevalence in patients with chronic limb-threatening ischaemia. During the observation period, revascularisation procedures increased from 77.5% to 80.2%, while major amputations decreased from 13.2% to 7.9% and mortality decreased from 5.0% to 3.3%.
Conclusion: The inpatient burden of PAD is considerable in Slovenia. Patients hospitalised for PAD have a high burden of co-morbidities, especially when presenting with chronic limb-threatening ischaemia; nonetheless, in-hospital major amputations and mortality decreased substantially over the last decade.</dc:description><dc:date>2026</dc:date><dc:date>2026-02-26 21:34:08</dc:date><dc:type>Neznano</dc:type><dc:identifier>179917</dc:identifier><dc:language>sl</dc:language><dc:coverage>Vse slovenske bolnišnice</dc:coverage><dc:coverage>2015-2022</dc:coverage></metadata>
